Novartis Ag (NVS) Return on Invested Capital (2009 - 2026)

Novartis Ag has reported Return on Invested Capital for 12 years, with the latest figure at 0.01% in Q2 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital fell to 0.01% in Q2 2026 per NVS's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 5.87% in Q4 2022 and troughed at 0.01% in Q2 2026.
• A 5-year average of 2.44% and a median of 1.3% in 2023 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Return on Invested Capital jumped 377 bps in 2022, then sank 457 bps in 2023.
• Over 5 years, Return on Invested Capital stood at 5.87% in 2022, then sank by 78 bps to 1.3% in 2023, then slumped by 99 bps to 0.01% in 2024, then decreased by 6 bps to 0.01% in 2025, then slipped by 15 bps to 0.01% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.01%, and 0.01% for Q2 2026, Q2 2025, and Q4 2024 respectively.